The global mRNA Synthesis Service market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for mRNA Synthesis Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for mRNA Synthesis Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for mRNA Synthesis Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key mRNA Synthesis Service players cover APExBIO, Takeda Pharmaceuticals, Tesla, Thermo Fisher Scientific, VGXI, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥渕RNA Synthesis Service Industry Forecast鈥� looks at past sales and reviews total world mRNA Synthesis Service sales in 2024, providing a comprehensive analysis by region and market sector of projected mRNA Synthesis Service sales for 2025 through 2031. With mRNA Synthesis Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Synthesis Service industry.
This Insight Report provides a comprehensive analysis of the global mRNA Synthesis Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on mRNA Synthesis Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global mRNA Synthesis Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Synthesis Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Synthesis Service.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Synthesis Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
mRNA Vaccine Synthesis
mRNA Drug Synthesis
Segmentation by Application:
Clinical
Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
APExBIO
Takeda Pharmaceuticals
Tesla
Thermo Fisher Scientific
VGXI
WACKER Chemie
Siegfried
ST Pharm
Novartis
Novo Nordisk
Pfizer
LakePharma
Lion TCR
Lonza
Merck
GlaxoSmithKline
GenePharma
Fareva
Fosun Pharma
GC Pharma
Syneos Health
Bayer
Beijing Tricision Biotherapeutics
Cellerna
Eli Lilly
CMC Pharmaceuticals
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global mRNA Synthesis Service Market Size (2020-2031)
2.1.2 mRNA Synthesis Service Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for mRNA Synthesis Service by Country/Region (2020, 2024 & 2031)
2.2 mRNA Synthesis Service Segment by Type
2.2.1 mRNA Vaccine Synthesis
2.2.2 mRNA Drug Synthesis
2.3 mRNA Synthesis Service Market Size by Type
2.3.1 mRNA Synthesis Service Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global mRNA Synthesis Service Market Size Market Share by Type (2020-2025)
2.4 mRNA Synthesis Service Segment by Application
2.4.1 Clinical
2.4.2 Research
2.4.3 Others
2.5 mRNA Synthesis Service Market Size by Application
2.5.1 mRNA Synthesis Service Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global mRNA Synthesis Service Market Size Market Share by Application (2020-2025)
3 mRNA Synthesis Service Market Size by Player
3.1 mRNA Synthesis Service Market Size Market Share by Player
3.1.1 Global mRNA Synthesis Service Revenue by Player (2020-2025)
3.1.2 Global mRNA Synthesis Service Revenue Market Share by Player (2020-2025)
3.2 Global mRNA Synthesis Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 mRNA Synthesis Service by Region
4.1 mRNA Synthesis Service Market Size by Region (2020-2025)
4.2 Global mRNA Synthesis Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas mRNA Synthesis Service Market Size Growth (2020-2025)
4.4 APAC mRNA Synthesis Service Market Size Growth (2020-2025)
4.5 Europe mRNA Synthesis Service Market Size Growth (2020-2025)
4.6 Middle East & Africa mRNA Synthesis Service Market Size Growth (2020-2025)
5 Americas
5.1 Americas mRNA Synthesis Service Market Size by Country (2020-2025)
5.2 Americas mRNA Synthesis Service Market Size by Type (2020-2025)
5.3 Americas mRNA Synthesis Service Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Synthesis Service Market Size by Region (2020-2025)
6.2 APAC mRNA Synthesis Service Market Size by Type (2020-2025)
6.3 APAC mRNA Synthesis Service Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe mRNA Synthesis Service Market Size by Country (2020-2025)
7.2 Europe mRNA Synthesis Service Market Size by Type (2020-2025)
7.3 Europe mRNA Synthesis Service Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa mRNA Synthesis Service by Region (2020-2025)
8.2 Middle East & Africa mRNA Synthesis Service Market Size by Type (2020-2025)
8.3 Middle East & Africa mRNA Synthesis Service Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global mRNA Synthesis Service Market Forecast
10.1 Global mRNA Synthesis Service Forecast by Region (2026-2031)
10.1.1 Global mRNA Synthesis Service Forecast by Region (2026-2031)
10.1.2 Americas mRNA Synthesis Service Forecast
10.1.3 APAC mRNA Synthesis Service Forecast
10.1.4 Europe mRNA Synthesis Service Forecast
10.1.5 Middle East & Africa mRNA Synthesis Service Forecast
10.2 Americas mRNA Synthesis Service Forecast by Country (2026-2031)
10.2.1 United States Market mRNA Synthesis Service Forecast
10.2.2 Canada Market mRNA Synthesis Service Forecast
10.2.3 Mexico Market mRNA Synthesis Service Forecast
10.2.4 Brazil Market mRNA Synthesis Service Forecast
10.3 APAC mRNA Synthesis Service Forecast by Region (2026-2031)
10.3.1 China mRNA Synthesis Service Market Forecast
10.3.2 Japan Market mRNA Synthesis Service Forecast
10.3.3 Korea Market mRNA Synthesis Service Forecast
10.3.4 Southeast Asia Market mRNA Synthesis Service Forecast
10.3.5 India Market mRNA Synthesis Service Forecast
10.3.6 Australia Market mRNA Synthesis Service Forecast
10.4 Europe mRNA Synthesis Service Forecast by Country (2026-2031)
10.4.1 Germany Market mRNA Synthesis Service Forecast
10.4.2 France Market mRNA Synthesis Service Forecast
10.4.3 UK Market mRNA Synthesis Service Forecast
10.4.4 Italy Market mRNA Synthesis Service Forecast
10.4.5 Russia Market mRNA Synthesis Service Forecast
10.5 Middle East & Africa mRNA Synthesis Service Forecast by Region (2026-2031)
10.5.1 Egypt Market mRNA Synthesis Service Forecast
10.5.2 South Africa Market mRNA Synthesis Service Forecast
10.5.3 Israel Market mRNA Synthesis Service Forecast
10.5.4 Turkey Market mRNA Synthesis Service Forecast
10.6 Global mRNA Synthesis Service Forecast by Type (2026-2031)
10.7 Global mRNA Synthesis Service Forecast by Application (2026-2031)
10.7.1 GCC Countries Market mRNA Synthesis Service Forecast
11 Key Players Analysis
11.1 APExBIO
11.1.1 APExBIO Company Information
11.1.2 APExBIO mRNA Synthesis Service Product Offered
11.1.3 APExBIO mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 APExBIO Main Business Overview
11.1.5 APExBIO Latest Developments
11.2 Takeda Pharmaceuticals
11.2.1 Takeda Pharmaceuticals Company Information
11.2.2 Takeda Pharmaceuticals mRNA Synthesis Service Product Offered
11.2.3 Takeda Pharmaceuticals mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Takeda Pharmaceuticals Main Business Overview
11.2.5 Takeda Pharmaceuticals Latest Developments
11.3 Tesla
11.3.1 Tesla Company Information
11.3.2 Tesla mRNA Synthesis Service Product Offered
11.3.3 Tesla mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Tesla Main Business Overview
11.3.5 Tesla Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific mRNA Synthesis Service Product Offered
11.4.3 Thermo Fisher Scientific mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 VGXI
11.5.1 VGXI Company Information
11.5.2 VGXI mRNA Synthesis Service Product Offered
11.5.3 VGXI mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 VGXI Main Business Overview
11.5.5 VGXI Latest Developments
11.6 WACKER Chemie
11.6.1 WACKER Chemie Company Information
11.6.2 WACKER Chemie mRNA Synthesis Service Product Offered
11.6.3 WACKER Chemie mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 WACKER Chemie Main Business Overview
11.6.5 WACKER Chemie Latest Developments
11.7 Siegfried
11.7.1 Siegfried Company Information
11.7.2 Siegfried mRNA Synthesis Service Product Offered
11.7.3 Siegfried mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Siegfried Main Business Overview
11.7.5 Siegfried Latest Developments
11.8 ST Pharm
11.8.1 ST Pharm Company Information
11.8.2 ST Pharm mRNA Synthesis Service Product Offered
11.8.3 ST Pharm mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 ST Pharm Main Business Overview
11.8.5 ST Pharm Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis mRNA Synthesis Service Product Offered
11.9.3 Novartis mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Novo Nordisk
11.10.1 Novo Nordisk Company Information
11.10.2 Novo Nordisk mRNA Synthesis Service Product Offered
11.10.3 Novo Nordisk mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Novo Nordisk Main Business Overview
11.10.5 Novo Nordisk Latest Developments
11.11 Pfizer
11.11.1 Pfizer Company Information
11.11.2 Pfizer mRNA Synthesis Service Product Offered
11.11.3 Pfizer mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Pfizer Main Business Overview
11.11.5 Pfizer Latest Developments
11.12 LakePharma
11.12.1 LakePharma Company Information
11.12.2 LakePharma mRNA Synthesis Service Product Offered
11.12.3 LakePharma mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 LakePharma Main Business Overview
11.12.5 LakePharma Latest Developments
11.13 Lion TCR
11.13.1 Lion TCR Company Information
11.13.2 Lion TCR mRNA Synthesis Service Product Offered
11.13.3 Lion TCR mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Lion TCR Main Business Overview
11.13.5 Lion TCR Latest Developments
11.14 Lonza
11.14.1 Lonza Company Information
11.14.2 Lonza mRNA Synthesis Service Product Offered
11.14.3 Lonza mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Lonza Main Business Overview
11.14.5 Lonza Latest Developments
11.15 Merck
11.15.1 Merck Company Information
11.15.2 Merck mRNA Synthesis Service Product Offered
11.15.3 Merck mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Merck Main Business Overview
11.15.5 Merck Latest Developments
11.16 GlaxoSmithKline
11.16.1 GlaxoSmithKline Company Information
11.16.2 GlaxoSmithKline mRNA Synthesis Service Product Offered
11.16.3 GlaxoSmithKline mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 GlaxoSmithKline Main Business Overview
11.16.5 GlaxoSmithKline Latest Developments
11.17 GenePharma
11.17.1 GenePharma Company Information
11.17.2 GenePharma mRNA Synthesis Service Product Offered
11.17.3 GenePharma mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 GenePharma Main Business Overview
11.17.5 GenePharma Latest Developments
11.18 Fareva
11.18.1 Fareva Company Information
11.18.2 Fareva mRNA Synthesis Service Product Offered
11.18.3 Fareva mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Fareva Main Business Overview
11.18.5 Fareva Latest Developments
11.19 Fosun Pharma
11.19.1 Fosun Pharma Company Information
11.19.2 Fosun Pharma mRNA Synthesis Service Product Offered
11.19.3 Fosun Pharma mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Fosun Pharma Main Business Overview
11.19.5 Fosun Pharma Latest Developments
11.20 GC Pharma
11.20.1 GC Pharma Company Information
11.20.2 GC Pharma mRNA Synthesis Service Product Offered
11.20.3 GC Pharma mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 GC Pharma Main Business Overview
11.20.5 GC Pharma Latest Developments
11.21 Syneos Health
11.21.1 Syneos Health Company Information
11.21.2 Syneos Health mRNA Synthesis Service Product Offered
11.21.3 Syneos Health mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Syneos Health Main Business Overview
11.21.5 Syneos Health Latest Developments
11.22 Bayer
11.22.1 Bayer Company Information
11.22.2 Bayer mRNA Synthesis Service Product Offered
11.22.3 Bayer mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Bayer Main Business Overview
11.22.5 Bayer Latest Developments
11.23 Beijing Tricision Biotherapeutics
11.23.1 Beijing Tricision Biotherapeutics Company Information
11.23.2 Beijing Tricision Biotherapeutics mRNA Synthesis Service Product Offered
11.23.3 Beijing Tricision Biotherapeutics mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.23.4 Beijing Tricision Biotherapeutics Main Business Overview
11.23.5 Beijing Tricision Biotherapeutics Latest Developments
11.24 Cellerna
11.24.1 Cellerna Company Information
11.24.2 Cellerna mRNA Synthesis Service Product Offered
11.24.3 Cellerna mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.24.4 Cellerna Main Business Overview
11.24.5 Cellerna Latest Developments
11.25 Eli Lilly
11.25.1 Eli Lilly Company Information
11.25.2 Eli Lilly mRNA Synthesis Service Product Offered
11.25.3 Eli Lilly mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.25.4 Eli Lilly Main Business Overview
11.25.5 Eli Lilly Latest Developments
11.26 CMC Pharmaceuticals
11.26.1 CMC Pharmaceuticals Company Information
11.26.2 CMC Pharmaceuticals mRNA Synthesis Service Product Offered
11.26.3 CMC Pharmaceuticals mRNA Synthesis Service Revenue, Gross Margin and Market Share (2020-2025)
11.26.4 CMC Pharmaceuticals Main Business Overview
11.26.5 CMC Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
